S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CYTK Cytokinetics Inc

64.055

2.74 (4.46%)

Last Updated: 04:58:14

Delayed by 15 minutes

Sec Staff Action/letter (sec Staff)

This regulatory filing also includes additional resources:
filename1.pdf

Cytokinetics (NASDAQ:CYTK)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Cytokinetics Charts.

Cytokinetics (NASDAQ:CYTK)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Cytokinetics Charts.

Cytokinetics Inc News

Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
Tuesday 30 April 2024 (2 days ago) • GlobeNewswire Inc.

Cytokinetics to Announce First Quarter Results on May 8, 2024
Thursday 25 April 2024 (7 days ago) • GlobeNewswire Inc.

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
Wednesday 10 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
Friday 5 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 3 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Tuesday 2 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

More Cytokinetics Inc News Articles

Woodside Petroleum

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions